Investing Profile

Laia Crespo

InvestorVC
Head of Investments at Sanofi Ventures
Photo of Laia Crespo, Investor at Sanofi Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$5.0M - $10.0M
$7.5M
9
CompanyStageDateRound SizeTotal Raised
Eligo Bioscience
Series BDec 2023$30M
$48M
Co-investors: Samir Kaul (Khosla Ventures)
QurAlis
Series BMar 2023$88M
$140M
Co-investors: Amy Schulman (Polaris Partners), Roel Bulthuis (INKEF Capital), Johannes Fruehauf (Mission BioCapital), Philip Scheltens (EQT Life Sciences), Cillian King (EQT Life Sciences), Jeffrey Moore (MP Healthcare Venture Management), Stephen Thompson (Brandon Capital Partners)
OMass Therapeutics
Series BApr 2022$95M
$95M
Co-investors: Scott Biller (GV (Google Ventures)), Diana Bernstein (Northpond Ventures)
Lava Therapeutics
Series CSep 2020$83M
$100M
Co-investors: Guido Magni (Versant Ventures), Nanna Luneborg (Forbion), Joël Jean-Mairet (Ysios Capital)
Inbiomotion
Series BMar 2016$2M
Series AJun 2012$2M
$4M
Co-investors: Joël Jean-Mairet (Ysios Capital), Jose Mesa (Alta Life Sciences)
Minoryx Therapeutics
Series AOct 2015$22M
$81M
Co-investors: Carlos Esteban (Faber), Pablo Cironi (Caixa Capital), Thierry Laugel (Kurma Partners), Monique Schiersing (Roche Venture Fund)
AM Pharma
Series ESep 2014$16M
Series DSep 2011$40M
$210M
Co-investors: Raphael Wisniewski (Andera Partners), Geert-Jan Mulder (Forbion), Rémi Droller (Kurma Partners), Joël Jean-Mairet (Ysios Capital), Martijn Kleijwegt (EQT Life Sciences), Felice Verduyn - van Weegen (EQT Life Sciences)